The Most Valuable Pill in the World will double your moneyStansberry research is touting a biotech pick that will cure a disease that kills 1 out of 4 people. What is it?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
I was trying to figure this out myself, after doing a little research i think the ticker is ESPR.. @ $43/Share roughly…. The disease is heart disease, but their medicine targets high cholesterol, which I am guessing is a contributing factor to heart disease? Let me know what you guys think!
I think you’re right, we covered that one here: https://www.stockgumshoe.com/reviews/stansberry-venture/stansberry-ventures-most-valuable-pill-in-development-anywhere-pitch/